Free Access
Issue
J Extra Corpor Technol
Volume 46, Number 3, September 2014
Page(s) 254 - 257
DOI https://doi.org/10.1051/ject/201446254
Published online 15 September 2014
  1. Halbmayer WM, Haushofer A, Schon R, et al. The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: Evaluation of the incidence of FXII deficiency among 300 healthy blood donors. Thromb Haemost. 1994;71:68–72. [Google Scholar]
  2. Despotis GJ, Filos KS, Zoys TN, Hogue CWJr, Spitznagel E, Lappas DG. Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: A multivariate analysis in cardiac surgical patients. Anesth Analg. 1996;82:13–21. [Google Scholar]
  3. Stratta P, Canavese C, Costa P, et al. Biological stress induced by extracorporeal circulation: Comparison between cardiopulmonary bypass, hemodialysis and plasma exchange. Trans Am Soc Artif Intern Organs. 1984;30:502–507. [PubMed] [Google Scholar]
  4. Tanaka K, Takao M, Yada I, Yuasa H, Kusagawa M, Deguchi K. Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery. J Cardiothorac Anesth. 1989;3:181–188. [CrossRef] [Google Scholar]
  5. Moorman RM, Reynolds DS, Comunale ME. Management of cardiopulmonary bypass in a patient with congenital factor XII deficiency. J Cardiothorac Vasc Anesth. 1993;7:452–454. [CrossRef] [Google Scholar]
  6. Tans G, Rosing J. Structural and functional characterization of factor XII. Semin Thromb Hemost. 1987;13:1–14. [Google Scholar]
  7. Horton S, Augustin S. Activated clotting time (ACT). Methods Mol Biol. 2013;992:155–167. [CrossRef] [PubMed] [Google Scholar]
  8. Wallock M, Arentzen C, Perkins J. Factor XII deficiency and cardiopulmonary bypass. Perfusion. 1995;10:13–16. [CrossRef] [PubMed] [Google Scholar]
  9. Koster A, Fischer T, Praus M, et al. Hemostatic activation and inflammatory response during cardiopulmonary bypass: Impact of heparin management. Anesthesiology. 2002;97:837–841. [CrossRef] [PubMed] [Google Scholar]
  10. Wallock M, Arentzen C, Perkins J. Factor XII deficiency and cardiopulmonary bypass. Perfusion. 1995;10:13–16. [CrossRef] [PubMed] [Google Scholar]
  11. Wood MK. Congenital factor XII deficiency and cardiopulmonary bypass. Ann Thorac Surg. 1994;58:1565. [CrossRef] [PubMed] [Google Scholar]
  12. Gerhardt MA, Greenberg CS, Slaughter TF, Stafford Smith M. Factor XII deficiency and cardiopulmonary bypass: Use of a novel modification of the activated clotting time to monitor anticoagulation. Anesthesiology. 1997;87:990–992. [CrossRef] [PubMed] [Google Scholar]
  13. Cankovic L, Steenwyk BL, McGiffin DC, Nielsen VG. Practical approach to anticoagulation for cardiopulmonary bypass in the patient with congenital prolonged activated partial thromboplastin time. Blood Coagul Fibrinolysis. 2008;19:725–726. [CrossRef] [PubMed] [Google Scholar]
  14. Burman JF, Chung HI, Lane DA, Philippou H, Adami A, Lincoln JC. Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypass. Lancet. 1994;344:1192–1193. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.